spectinomycin has been researched along with Tuberculosis in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chibale, K; Kigondu, EM; Warner, DF; Wasuna, A | 1 |
| Fontaine, E; Roubert, C; Upton, AM | 1 |
| Gonzalez-Juarrero, M; Hickey, AJ; Kodidela, S; Kumar, S; Lee, RE; Liu, J; Meibohm, B; Robertson, GT; Temrikar, ZH | 1 |
| Braunstein, M; Gonzalez-Juarrero, M; Hickey, A; Lee, RE; Lenaerts, AJ; Lukka, PB; Meibohm, B; Rathi, C; Wagh, S | 1 |
| Braunstein, M; Creissen, E; Gonzalez-Juarrero, M; Hickey, AJ; Lukka, PB; Meibohm, B; Pearce, C; Walz, A | 1 |
| Boyd, VA; Jeffries, C; Lee, RE; Liu, J; Loveless, V; Madhura, DB; Meibohm, B; Trivedi, A | 1 |
| Bowlin, TL; Bruhn, DF; Butler, MM; Hastings, C; Lee, RB; Lee, RE; Lenaerts, AJ; Liu, J; McNeil, MR; Robertson, GT; Scherman, MS | 1 |
| Anderson, H; Av-Gay, Y; Chao, JD; Ng, C; Pfeifer, T; Ramón-García, S; Roberge, M; Thompson, CJ; Zheng, X | 1 |
1 review(s) available for spectinomycin and Tuberculosis
| Article | Year |
|---|---|
Pharmacologically active metabolites, combination screening and target identification-driven drug repositioning in antituberculosis drug discovery.
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Drug Discovery; Fusidic Acid; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis | 2014 |
7 other study(ies) available for spectinomycin and Tuberculosis
| Article | Year |
|---|---|
"Upcycling" known molecules and targets for drug-resistant TB.
Topics: Antitubercular Agents; beta-Lactams; Ethionamide; Humans; Spectinomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2022 |
Characterization of spectinamide 1599 efficacy against different mycobacterial phenotypes.
Topics: Antitubercular Agents; Humans; Mycobacterium bovis; Mycobacterium tuberculosis; Spectinomycin; Tuberculosis | 2023 |
Comparative pharmacokinetics of spectinamide 1599 after subcutaneous and intrapulmonary aerosol administration in mice.
Topics: Administration, Inhalation; Animals; Antitubercular Agents; Biological Availability; Drug Evaluation, Preclinical; Female; Injections, Subcutaneous; Lung; Mice, Inbred BALB C; Spectinomycin; Tuberculosis | 2019 |
Sterilization of Mycobacterium tuberculosis infected samples using methanol preserves anti-tuberculosis drugs for subsequent pharmacological testing studies.
Topics: Animals; Antitubercular Agents; Colony Count, Microbial; Feasibility Studies; Female; Laboratory Infection; Lung; Methanol; Mice, Inbred BALB C; Microbial Sensitivity Tests; Microbial Viability; Mycobacterium tuberculosis; Specimen Handling; Spectinomycin; Stem Cells; Sterilization; Tuberculosis | 2019 |
Tissue Penetration of a Novel Spectinamide Antibiotic for the Treatment of Tuberculosis.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Male; Mice; Rats; Rats, Sprague-Dawley; Spectinomycin; Tissue Distribution; Treatment Outcome; Tuberculosis | 2016 |
Spectinamides are effective partner agents for the treatment of tuberculosis in multiple mouse infection models.
Topics: Animals; Antitubercular Agents; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Lung; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Pyrazinamide; Quinolines; Rifampin; Spectinomycin; Tuberculosis | 2017 |
Synergistic drug combinations for tuberculosis therapy identified by a novel high-throughput screen.
Topics: Antitubercular Agents; Drug Synergism; Drug Therapy, Combination; Haloperidol; High-Throughput Screening Assays; Humans; Macrophages; Mycobacterium smegmatis; Mycobacterium tuberculosis; Spectinomycin; Tuberculosis | 2011 |